https://clinicaltrials.gov/ct2/show/NCT03272165?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=04%2F29%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Single Ascending Dose Study of MEDI1341 in Healthy Volunteers
DESCRIPTION:
Condition: Parkinson’s Disease
Interventions: Drug: MEDI1341; Drug: Placebo
Sponsors: AstraZeneca; Covance; MMS Holdings, Inc; Catalent
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03272165
FIRST POSTED:
Tue, 05 Sep 2017 12:00:00 EDT
LAST UPDATE POSTED:
05/13/19 07:43AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03272165?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=04%2F29%2F2019&lupd_d=14&sort=nwst
